Clover Health's pivot to profitability over growth has led to significant earnings improvements. See why I rate CLOV stock as ...

Standard metrics may mask potential issues, but construction leaders have leveraged fresh methods to record data and abate ...

Focus has got to be on extraction of value from the UK assets to leverage into other jurisdictions,” chief executiveAndrew ...

Key among these is the pivot towards a payor/Direct to Employer (DTE) strategy, which represents a significant shift in the company's go-to-market approach. This evolution is designed to tap into ...

Novo Nordisk reported mixed Q3 earnings, but GLP-1 drugs contributed to revenue strength. The company also adjusted its ...

Today, the thesis that may have justified Rivian'speak valuation of over $153 billion (the company is worth just over $10 billion today) has largely evaporated. Growth for the pure-play EV companies ...

Changing careers can be daunting; you need more than financial stability. Here are the four capital pillars needed when ...

The manufacture and distribution of industrial explosives, industrial chemicals and fertilisers and the provision of related services.

Even though there will be help from mentors and employers along the way, investing in yourself is the most crucial and ...

But instead of just spiking the football after a decade of cord-cutting coverage, let’s review the tape on where I went wrong ...

Infosys, Wipro, and HCLTech get a lion's share of their revenue from US clients and any uptick in client spend directly boosts their topline.

Codexis's pivot to RNAi therapeutics represents a significant shift from its traditional enzyme engineering focus. This transition carries execution risks as the company enters a new market segment.